PLK4 Gene

Overview

flowchart TD
    PLK4["PLK4"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
    PLK4["PLK4"] -->|"therapeutic target"| Parkinson["Parkinson"]
    PLK4["PLK4"] -->|"associated with"| Alzheimer["Alzheimer"]
    PLK4["PLK4"] -->|"associated with"| Parkinson["Parkinson"]
    PLK4["PLK4"] -->|"associated with"| FCGRT["FCGRT"]
    PLK4["PLK4"] -->|"associated with"| PI3K["PI3K"]
    PLK4["PLK4"] -->|"therapeutic target"| Stat3["Stat3"]
    PLK4["PLK4"] -->|"associated with"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    PLK4["PLK4"] -->|"therapeutic target"| Pi3K["Pi3K"]
    PLK4["PLK4"] -->|"therapeutic target"| Akt["Akt"]
    PLK4["PLK4"] -->|"therapeutic target"| App["App"]
    PLK4["PLK4"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
    PLK4["PLK4"] -->|"interacts with"| FCGRT["FCGRT"]
    CASP3["CASP3"] -->|"therapeutic target"| PLK4["PLK4"]
    style PLK4 fill:#4fc3f7,stroke:#333,color:#000

PLK4 (Polo-Like Kinase 4) is a serine/threonine protein kinase that serves as the master regulator of centriole duplication, playing a critical role in microtubule organization, ciliogenesis, and cell cycle progression. As a member of the Polo-like kinase family, PLK4 has unique functions in controlling centriole copy number and ensuring proper mitotic spindle formation. [1] While PLK4 is primarily studied in the context of cell division and cancer, emerging evidence suggests important roles in post-mitotic neurons and neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis (ALS). ^{1PLK4 in centriole duplication (2012)2012 · DOI 10.1038/nrm3359Open reference}

Gene Information

Protein Structure and Function

Structural Features

The PLK4 protein contains several key structural domains: [2]

1. N-terminal Kinase Domain: Catalytic serine/threonine kinase domain

2. Polo Box Domain (PBD): C-terminal polo boxes that mediate substrate recognition and localization

3. Leucine Zipper: Involved in protein-protein interactions

4. HAUS Algorithm Domain: For proper centrosome function

Molecular Functions

PLK4 performs several critical molecular functions:

• Centriole Duplication: Acts as the master regulator ensuring one centriole per cell cycle

• Kinase Activity: Phosphorylates downstream targets to promote centriole formation

• Cell Cycle Regulation: Controls G1/S transition and mitotic entry

• Ciliogenesis: Required for primary cilia formation in interphase cells

Key Pathways and Interactions

Cell Cycle Control

PLK4 interacts with key cell cycle regulators:

• STIL: Critical co-factor for centriole duplication

• SAS-6: Central scaffold for centriole assembly

• CPAP: Centriolar pore-like structure protein

• CDK2: Cell division kinase regulating G1/S transition

• AURKA: Aurora kinase A, coordinates centriole maturation

Centrosome Regulation

• Centriole Cohesion: PLK4 regulates centriole separation

• Spindle Orientation: Controls mitotic spindle assembly

• Microtubule Anchoring: Ensures proper microtubule organization

Expression Pattern

Brain Regional Expression

PLK4 is expressed in the central nervous system:

• Cerebral Cortex: Moderate expression in pyramidal neurons

• Hippocampus: Expression in CA regions and dentate gyrus

• Subventricular Zone: High expression in neural progenitor cells

• Cerebellum: Expression in granule cell precursors

Cell Type Specificity

• Neural Progenitor Cells: High expression during active proliferation

• Neurons: Lower expression in mature neurons (post-mitotic)

• Astrocytes: Moderate expression

• Microglia: Lower expression

Disease Associations

Microcephaly

PLK4 mutations cause primary microcephaly: [3]

• Autosomal Recessive Inheritance: Biallelic mutations lead to severe microcephaly

• Mechanism: Impaired neural progenitor cell division during brain development

• Phenotype: Reduced brain size, intellectual disability

Alzheimer’s Disease

PLK4 dysfunction may contribute to Alzheimer’s disease pathogenesis:

• Centrosome Dysfunction: Impaired centriole function may affect neuronal polarity

• Cell Cycle Re-entry: Some evidence suggests neurons attempt cell cycle re-entry in AD

• Tau Pathology: PLK4 may interact with tau phosphorylation pathways

• Therapeutic Implications: PLK4 modulators may have neuroprotective potential

Parkinson’s Disease

In Parkinson’s disease:

• Dopaminergic Neuron Development: PLK4 important for development of substantia nigra neurons

• Cellular Stress Response: PLK4 may respond to oxidative stress in neurons

Amyotrophic Lateral Sclerosis (ALS)

In ALS:

• Motor Neuron Development: PLK4 critical for motor neuron specification

• Axonal Transport: Centrosome function may affect axonal transport

Cancer

PLK4 is dysregulated in multiple cancers: [4]

• Oncogenic Function: Overexpression in various tumor types

• Genomic Instability: PLK4 alterations contribute to aneuploidy

• Therapeutic Target: PLK4 inhibitors being developed for cancer therapy

Therapeutic Implications

Kinase Inhibitors

• PLK4 Inhibitors: Several small molecules inhibit PLK4 kinase activity

• Cancer Therapy: PLK4 as potential therapeutic target in cancer

Gene Therapy

• Microcephaly Treatment: Gene therapy approaches for PLK4 mutations

• Neuroprotection: Modulating PLK4 for neurodegenerative diseases

Interacting Proteins

Key protein interactions include:

• STIL: Critical co-factor for centriole duplication

• SAS6: Centriolar scaffold protein

• CPAP: Centriolar protein

• CDK2: Cell cycle kinase

• AURKA: Aurora kinase A

Animal Models

Knockout Studies

• Plk4-/- mice: Embryonic lethal, severe developmental defects

• Heterozygous mice: Reduced centriole number, cancer predisposition

Transgenic Models

• PLK4 overexpression: Centrosome amplification, genomic instability

• PLK4 deficiency: Microcephaly phenotype

See Also

• Cell Cycle in Neurodegeneration

• Centrosome Function

• Alzheimer’s Disease

• Parkinson’s Disease

• ALS

External Links

• NCBI Gene: PLK4

• UniProt: Q9Y5A9

• Human Protein Atlas: PLK4